Category: Drug recalls

Since 2023, the FDA has coordinated several eye drop recalls impacting numerous brands due to serious contamination and manufacturing issues. This article provides a crucial breakdown of **what brands of eye drops are recalled** and why, to help protect your eye health.

Several recalls for timolol maleate ophthalmic solutions have been issued in recent years, including multiple notices in 2024 and 2025 by FDC Limited and its distributor Rising Pharmaceuticals. These recalls primarily stemmed from issues with defective product containers, highlighting the need for patients to be vigilant about medication safety.

While there is no current widespread, active recall on all fluticasone products, multiple specific lots from manufacturers, including Apotex Corp. and Akorn, Inc., have been recalled in recent years due to issues ranging from glass particles to microbial concerns. This history highlights the importance of checking product details for safety alerts, particularly concerning generic versions of fluticasone.

The U.S. Food and Drug Administration (FDA) recommends that consumers do not use any products containing phenylpropanolamine due to its association with an increased risk of hemorrhagic stroke. Therefore, the question of **how many days should I take phenylpropanolamine?** is moot, as it is no longer available for human use in the U.S..

Several batches of generic amitriptyline have been recalled in recent years by regulatory bodies like Health Canada and Singapore's HSA due to quality control issues. Patients often ask, "Why was amitriptyline recalled?" to understand if their medication is affected, but it's important to differentiate specific batch recalls from the general safety profile of the medication itself.

In 2012, a specific generic version of bupropion, Budeprion XL 300mg, was voluntarily withdrawn from the market by its manufacturers, Teva and Impax, after an FDA study confirmed it was not therapeutically equivalent to the brand-name drug. This action led many patients to question why was bupropion taken off the market.

In April 2020, the U.S. Food and Drug Administration (FDA) took the historic step of requesting the immediate market withdrawal of all prescription and over-the-counter (OTC) ranitidine products, commonly known by the brand name Zantac. This definitive action was prompted by growing evidence that the drug was contaminated with a probable human carcinogen called N-nitrosodimethylamine (NDMA).

In one of the largest voluntary drug recalls in history, Merck & Co. withdrew its blockbuster arthritis drug Vioxx (rofecoxib) from the worldwide market on September 30, 2004. The recall followed concerns and clinical trial data indicating Vioxx increased the risk of heart attack and stroke.

In November 2010, the U.S. Food and Drug Administration (FDA) requested a recall of all propoxyphene-containing medications, including the pink pill with 1772 on it, due to the risk of serious and potentially fatal heart rhythm abnormalities. This prescription medication, once widely used for mild to moderate pain, is no longer legally available in the United States and should be disposed of safely.